Skip to content

Clinical trials

Phase 2 Alopecia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alopecia Phase: Phase 2 Country / region: United States Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20094
20104
20113
20121
20131
20142
20153
20164
20183
20202
20211
20224
20234
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Active, not recruiting4
Recruiting3
Terminated3
Unknown status2
Withdrawn1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aderans Research Institute11
Allergan4
Emma Guttman3
Aclaris Therapeutics, Inc.2
Biosplice Therapeutics, Inc.2
Pfizer2
Almirall, S.A.1
Icahn School of Medicine at Mount Sinai1
Incyte Corporation1
Intrepid Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alopecia44
Alopecia Areata9
Acne Vulgaris1
Dermatitis1
Hirsutism1
Hypotrichosis1
Insulin Resistance1
Lichen Planus1
Menstruation Disturbances1
Polycystic Ovary Syndrome1

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.